Atara Biotherapeutics
ATRA
$0.56
Share price
-1.28%
Change (1 day)
-63.34%
Change (1 year)
Categories
Atara Biotherapeutics (ATRA) - P/B ratio
P/B ratio as of June 2024 : -0.6960
According to Atara Biotherapeutics's latest financial reports the company has a price-to-book ratio of -0.6960.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
Atara Biotherapeutics - P/B ratio (from 2014 to 2024)
P/B ratio by year
| Year | P/B ratio | Change |
|---|---|---|
| 2024-12-31 | N/A | -100% |
| 2023-12-31 | -0.5267 | -121.43% |
| 2022-12-31 | 2.46 | -52.44% |
| 2021-12-31 | 5.17 | 45.97% |
| 2020-12-31 | 3.54 | 10.02% |
| 2019-12-31 | 3.22 | -31.7% |
| 2018-12-31 | 4.71 | 51.31% |
| 2017-12-31 | 3.11 | 92.77% |
| 2016-12-31 | 1.62 | -32.29% |
| 2015-12-31 | 2.39 | -53.28% |
| 2014-12-31 | 5.11 | |
| 2013-12-31 | N/A |
P/B ratio for similar companies or competitors
| Company | P/B ratio | differencediff. | Country |
|---|---|---|---|
 ImmunoGen
IMGN | 15.5 | -2,332.06% | 🇺🇸 USA |
 Agenus
AGEN | -1.67 | 139.54% | 🇺🇸 USA |
 Affimed
AFMD | 0.9673 | -238.99% | 🇩🇪 Germany |